Mehmet Taha Yıldız

Mehmet Taha Yıldız

Auto-generated profile, based on publicly available information

Mehmet Taha Yıldız

Fatih University, Faculty of Sciences, Department of Biology, Buyukcekmece Campus, 34500 Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2005 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
GTGülhan Turan-Zitouni
Gülhan Turan-Zitouni
ZKZafer Asım Kaplancıklı
Zafer Asım Kaplancıklı
MYMehmet Taha Yıldız
Mehmet Taha Yıldız
PCPierre Chevallet
Pierre Chevallet
DKDemet Kaya
Demet Kaya

1 March 2004 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
GTGülhan Turan-Zitouni
Gülhan Turan-Zitouni
ŞDŞeref Demirayak
Şeref Demirayak
Ahmet ÖzdemirAhmet Özdemir
Ahmet Özdemir
ZKZafer Asım Kaplancıklı
Zafer Asım Kaplancıklı
MYMehmet Taha Yıldız
Mehmet Taha Yıldız

13 September 2014 in Annals of Hematology
Verified
Journal Article
Closed access
PDF file
SISevim Isik
Sevim Isik
MZMerve Zaim
Merve Zaim
MYMehmet Taha Yildiz
Mehmet Taha Yildiz
YNYesim Negis
Yesim Negis
TKTuba Kunduraci
Tuba Kunduraci
GCGuven Cetin
Guven Cetin

20 August 2020 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
MEMustafa Ergul
Mustafa Ergul
FAFugen Aktan
Fugen Aktan
MYMehmet T. Yildiz
Mehmet T. Yildiz
YTYusuf Tutar
Yusuf Tutar
Background: Heat shock protein 70 (HSP70) is constitutively expressed in normal cells but aberrantly expressed in several types of tumor cells, helping their survival in extreme conditions. Thus, specific inhibition of HSP70 in tumor cells is a promising strategy in the treatment of cancer. HSP70 has a variety of isoforms in the cellular organelles and form different functions by coordinating and cooperating with cochaperones. Cancer cells overexpress HSPs during cell growth and proliferation and HSP network provides resistance against apoptosis. The present study aimed to evaluate quantitative changes in HSPs- and cancerassociated gene expressions and their interactions in the presence of 2-phenylethyenesulfonamide (PES) in MCF-7 cells. Methods: Antiproliferative activity of PES was evaluated using the XTT assay. Inducible HSP70 (HSP70i) levels in the PES-treated cells were determined using the ELISA kit. PCR Array was performed to assess the HSPs- and cancer-pathway focused gene expression profiling. Gene network analysis was performed using the X2K, yEd (V.3.18.1) programs, and web-based gene list enrichment analysis tool Enrichr. Results: The results demonstrated that PES exposure increased the amount of both HSP70i gene and protein expression surprisingly. However, the expression of HSP70 isoforms as well as other co-chaperones, and 17 cancer-associated genes decreased remarkably as expected. Additionally, interaction network analysis revealed a different mechanism; PES induction of HSP70i employs a cell cycle negative regulator, RB1, which is a tumor suppressor gene. Conclusion: PES treatment inhibited MCF-7 cell proliferation and changed several HSPs- and cancer-related gene expressions along with their interactions through a unique mechanism although it causes an interesting increase at HSP70i gene and protein expressions. RB1 gene expression may play an important role in this effect as revealed by the interaction network analysis.

4 June 2019 in Journal of Food Biochemistry
Verified
Journal Article
Closed access
PDF file
STSule Terzioglu‐Usak
Sule Terzioglu‐Usak
MYMehmet Taha Yildiz
Mehmet Taha Yildiz
BGBeyza Goncu
Beyza Goncu
NONur Ozten‐Kandas
Nur Ozten‐Kandas